References
- Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, . Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557–67.
- Burzotta F, Trani C, Romagnoli E, Mazzari MA, Rebuzzi AG, De Vita M, . Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol. 2005;46:371–6.
- Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570–80.
- Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T, . Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002;106:1672–7.
- Lefkovits J, Holmes DR, Califf RM, Safian RD, Pieper K, Keeler G, . Predictors and sequalae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Circulation 1995;92:734–40.
- Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, . Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400–5.
- Burzotta F, Trani C, Romagnoli E, De Vita M, Talarico GP, Ferrante G, . Feasibility of sequential thrombus aspiration and filter distal protection in the management of very high thrombus burden lesions. J Invasive Cardiol. 2007;19:317–23.
- Jim MH, Ho HH, Chow WH. Export aspiration catheter enhanced FilterWire EX/EZ™ delivery: an innovative strategy for saphenous vein graft disease. J Invasive Cardiol. 2006;18:569–74.
- Porto I, Choudhury RP, Pillay P, Burzotta F, Trani C, Niccoli G, . Filter no reflow during percutaneous coronary interventions using the FilterWire EX/EZ distal protection device. Int J Cardiol. 2006;109:53–8.
- Vrints CJ. Pathophysiology of the no-reflow phenomenon. Acute Card Care 2009;11:69–76.
- Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, . Saphenous vein graft stenting and major adverse cardiac events: A predictive model derived from a pooled analysis of 3958 patients. Circulation 2008;117:790–7.
- Webb JG, Carere RG, Virmani R, Baim D, Teirstein PS, Whitlow P, . Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol. 1999;34:468–75.
- Grube E, Gerckens U, Yeung AC, Rowold S, Kirchhof N, Sedgewick J, . Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001;104:2436–41.
- Kirtane AJ, Heyman ER, Metzger C, Breall JA, Carrozza JP Jr. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: A PRIDE substudy. JACC Cardiovasc Interv. 2008;1:186–91.
- Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38:659–65.
- Niccoli G, Lanza GA, Shaw S, Romagnoli E, Gioia D, Burzotta F, . Endothelin-1 and acute myocardial infarction: A no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J. 2006;27:1793–8.
- Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, . Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J. 2008;29:1843–50.
- Castagna MT, Mintz GS, Ohlmann P, Kotani J, Maehara A, Gevorkian N, . Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: An intravascular ultrasound and angiographic study. Circulation 2005;111:1148–52.
- Jim MH, Hau WK, Ko RL, Siu CW, Ho HH, Yiu KH, . Virtual histology by intravascular ultrasound study on degenerative aortocoronary saphenous vein grafts. Heart Vessels 2010;25:175–81.